Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
06 juin 2024 02h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, June 06, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink Target 48 Immune Surveillance, a validated multiplexed protein...
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
30 mai 2024 08h00 HE
|
Olink Proteomics AB
Landmark study using the Olink Explore platform identifes proteins in the blood that may provide a 7-year warning for various cancers.
Olink reports first quarter 2024 financial results
13 mai 2024 06h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, May 13, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the first quarter ended March 31, 2024. ...
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
19 avr. 2024 16h05 HE
|
Olink Proteomics AB
UPPSALA, Sweden, April 19, 2024 (GLOBE NEWSWIRE) -- At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), on 19 April 2024 the AGM adopted,...
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
02 avr. 2024 08h00 HE
|
Olink Proteomics AB
Olink delivers new open access data library consisting of over 300,000 protein-disease risk associations across 106 human diseases.
Olink publishes 2023 annual report
25 mars 2024 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Annual Report for 2023 is now available on the Company’s website at...
Olink reports fourth quarter and full year 2023 financial results
25 mars 2024 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the fourth quarter ended December 31, 2023. ...
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
15 mars 2024 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, March 15, 2024 (GLOBE NEWSWIRE) -- The shareholders of Olink Holding AB (publ) (the “Company” or “Olink”), reg. no. 559189-7755, are hereby given notice to attend the Annual General...
Olink announces change of date for Annual General Meeting
08 mars 2024 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, March 08, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Olink’s 2024 Annual General Meeting (“AGM”) will be held in Uppsala, Sweden...
Olink reports third quarter 2023 financial results
15 nov. 2023 07h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the third quarter ended September 30, 2023. ...